Chlorpromazine in Chronic Schizophrenia

作者: Mervin L. Clark

DOI: 10.1001/ARCHPSYC.1972.01750280047009

关键词:

摘要: Behavioral data from a previous study were stratified by age ( 40 years) and duration of hospitalization 10 examined for dose-response relationships at the 12th week treatment with either placebo or 150, 300, 600 mg chlorpromazine per day. It was found that shorter hospitalized patients older ≥ achieved no improvement in response beyond 300 mg/day.

参考文章(5)
Robert F. Prien, High Dose Chlorpromazine Therapy in Chronic Schizophrenia Archives of General Psychiatry. ,vol. 18, pp. 482- 495 ,(1968) , 10.1001/ARCHPSYC.1968.01740040098013
Mervin L. Clark, H. Rudy Ramsey, Robert E. Ragland, Don K. Rahhal, Eustace A. Serafetinides, J. Paul Costiloe, Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships. Psychopharmacology. ,vol. 18, pp. 260- 270 ,(1970) , 10.1007/BF00412672
John E. Overall, Donald R. Gorham, The Brief Psychiatric Rating Scale Psychological Reports. ,vol. 10, pp. 799- 812 ,(1962) , 10.2466/PR0.1962.10.3.799
Mervin L. Clark, Thomas S. Ray, Alfonso Paredes, J. Paul Costiloe, John S. Chappell, James A. Hagans, Stewart Wolf, Chlorpromazine in chronic schizophrenic women: I. Experimental design and effects at maximum point of treatment Psychopharmacology. ,vol. 2, pp. 107- 136 ,(1961) , 10.1007/BF00592679